During the past decade, Lynderm Research, Inc. conducted 76 clinical trials. In the 10-year time frame, 76 clinical trials started and 59 clinical trials were completed, i.e. on average, 77.6% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 48 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lynderm Research, Inc." #1 sponsor was "Pfizer" with 22 trials, followed by "Eli Lilly and Company" with 9 trials sponsored, "Innovaderm Research Inc." with 9 trials sponsored, "Incyte Corporation" with 8 trials sponsored and "Amgen" with 8 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lynderm Research, Inc." #1 collaborator was "Abbott" with 3 trials as a collaborator, "Amgen" with 3 trials as a collaborator, "Dermira, Inc." with 3 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator and "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Lynderm Research, Inc." are "Psoriasis" (21 trials), "Atopic Dermatitis" (19 trials), "Plaque Psoriasis" (15 trials), "Acne Vulgaris" (9 trials) and "Alopecia Areata" (7 trials). Many other conditions were trialed in "Lynderm Research, Inc." in a lesser frequency.

Most popular intervention types in "Lynderm Research, Inc." are "Drug" (99 trials), "Other" (16 trials), "Biological" (8 trials), "Device" (4 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "Vehicle" (5 trials), "Apremilast" (4 trials), "PF-06651600" (4 trials) and "Ruxolitinib cream" (4 trials). Other intervention names were less common.

The vast majority of trials in "Lynderm Research, Inc." are 109 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Lynderm Research, Inc.". undefined are not yet recruiting, 4 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 78 completed trials in Lynderm Research, Inc., undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Lynderm Research, Inc., 5 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 2 trials that are defined as “Not Applicable".